Dimemorfan is a synthetic compound classified as an opioid analgesic, primarily used for its antitussive (cough-suppressing) properties. It is structurally related to morphine but has a distinct chemical configuration that contributes to its unique pharmacological profile. Dimemorfan acts on the central nervous system, specifically targeting opioid receptors, which helps alleviate cough without the sedative effects commonly associated with traditional opioids. This makes it a valuable option in cough management, particularly in cases where sedation is undesirable. The compound is typically administered in a medicinal form, and its efficacy and safety profile have been evaluated in clinical settings. As with other opioids, there is potential for misuse and dependence, necessitating careful monitoring and regulation. Dimemorfan's chemical structure includes a phenolic hydroxyl group, which is significant for its activity, and it is often formulated in combination with other ingredients to enhance its therapeutic effects. Overall, Dimemorfan represents an important tool in the pharmacological management of cough, balancing efficacy with a reduced risk of sedation.

Dimemorfan

36309-01-0: (9α,13α,14α)-3,17-Dimethylmorphinan, Dimemorfan [INN],  Morphinan, 3,17-dimethyl-, (9alpha,13alpha,14alpha)-, Dimemorfan,  UNII-623OAC38YU,  Dimemorfano [INN-Spanish], 3-Methyl-17-methylmorphinan,  3,N-Dimethylmorphinan,  Dimemorfano,  Dimemorfane,  Dimemorphan,  (13alpha,14alpha)-3,17-dimethylmorphinan, Morphinan, 3,17-dimethyl-, (9α,13α,14α)-,  (+)-3,17-Dimethylmorphinan,  Dimemorfanum [INN-Latin], Dimemorphan,  Dimemorfane [INN-French],  3,N-Dimethylmorphinan [IUPAC],  Dimemorfanum

CAS 36309-01-0: Dimemorfan

Morphine Impurity 7

Ref: 4Z-M-259045